AOLS (Aeolus Pharmaceuticals) Total Equity: $0.21 Mil (As of Jun. 2017)


What is Aeolus Pharmaceuticals Total Equity?

Aeolus Pharmaceuticals AOLS Total Equity is $0.21 Mil as of Jun. 2017.

Aeolus Pharmaceuticals's total equity for the quarter that ended in Jun. 2017 was $0.21 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Aeolus Pharmaceuticals Total Equity Historical Data

* Premium members only.

The historical data trend for Aeolus Pharmaceuticals's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aeolus Pharmaceuticals Total Equity Chart

Aeolus Pharmaceuticals Annual Data
Trend Sep07 Sep08 Sep09 Sep10 Sep11 Sep12 Sep13 Sep14 Sep15 Sep16
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -20.34 0.71 1.59 -0.85 3.20

Aeolus Pharmaceuticals Quarterly Data
Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.19 3.20 2.14 1.13 0.21

Aeolus Pharmaceuticals Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Aeolus Pharmaceuticals's Total Equity for the fiscal year that ended in Sep. 2016 is calculated as

Total Equity=Total Assets(Q: Sep. 2016 )-Total Liabilities(Q: Sep. 2016 )
=4.167-0.972
=3.20

Aeolus Pharmaceuticals's Total Equity for the quarter that ended in Jun. 2017 is calculated as

Total Equity=Total Assets(Q: Jun. 2017 )-Total Liabilities(Q: Jun. 2017 )
=0.794-0.587
=0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $0.21 Mil mean?
Aeolus Pharmaceuticals (AOLS) has a Total Equity of $0.21 Mil as of Jun. 2017. The total amount of equity as record on a company's balance sheet. View historical data for Aeolus Pharmaceuticals and its competitors.
Is Aeolus Pharmaceuticals' Total Equity too high?
Aeolus Pharmaceuticals' current Total Equity is $0.21 Mil.
How does Aeolus Pharmaceuticals' Total Equity compare to RDGL and PCYN?
Aeolus Pharmaceuticals' Total Equity of $0.21 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Drug Manufacturers company?
A good Total Equity depends on the Drug Manufacturers industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Aeolus Pharmaceuticals and its competitors. Aeolus Pharmaceuticals's current Total Equity is $0.21 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aeolus Pharmaceuticals stock overvalued right now?
Aeolus Pharmaceuticals (AOLS) has a current Total Equity of $0.21 Mil. The current Total Equity is $0.21 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Aeolus Pharmaceuticals (AOLS), the current Total Equity is $0.21 Mil as of Jun. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aeolus Pharmaceuticals Business Description

Address 26361 Crown Valley Parkway, Suite 150, Mission Viejo, CA, USA, 92691
Aeolus Pharmaceuticals Inc is a Southern California-based biopharmaceutical company. The company is developing a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious disease and diseases of the central nervous system. Aeolus is developing its lead compound, AEOL-10150, as a treatment for the lung effects of Acute Radiation Syndrome (Lung-ARS). Aeolus also has two pre-clinical development programs: AEOL 11114 and AEOL 20415.